Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!
- PMID: 34358567
- PMCID: PMC8330141
- DOI: 10.1016/j.jhep.2021.07.034
Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!
Keywords: COVID-19; Sars-CoV-2 vaccination; immunosuppression; liver transplantation.
Conflict of interest statement
Conflict of interest No personal or financial conflicts of interest for all the authors. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Reply to: "Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!".J Hepatol. 2022 Jan;76(1):239-240. doi: 10.1016/j.jhep.2021.09.037. Epub 2021 Oct 8. J Hepatol. 2022. PMID: 34634386 Free PMC article. No abstract available.
Comment on
-
Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.J Hepatol. 2021 Aug;75(2):435-438. doi: 10.1016/j.jhep.2021.04.020. Epub 2021 Apr 21. J Hepatol. 2021. PMID: 33892006 Free PMC article.
References
-
- Miele M., Busà R., Russelli G., Sorrentino M.C., Di Bella M., Timoneri F., et al. Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients. Am J Transplant. 2021 May 31 doi: 10.1111/ajt.16702. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
